Cite
MLA Citation
Chia-Chi Lin et al.. “387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A235. http://access.bl.uk/ark:/81055/vdc_100144727573.0x000007